scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JURO.2007.01.134 |
P698 | PubMed publication ID | 17509305 |
P50 | author | Steven J Frank | Q61160397 |
Deborah Kuban | Q109303827 | ||
P2093 | author name string | John Davis | |
Andrew K Lee | |||
Louis L Pisters | |||
Roland Bassett | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | iodine | Q1103 |
brachytherapy | Q896687 | ||
prostate cancer | Q181257 | ||
adaptive radiation therapy | Q180507 | ||
iodine in medicine | Q28196266 | ||
P304 | page(s) | 2151-6; discussion 2156 | |
P577 | publication date | 2007-06-01 | |
P1433 | published in | Journal of Urology | Q15709979 |
P1476 | title | An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer | |
P478 | volume | 177 |
Q37477409 | 125I Radioactive Seeds Implantation Therapy for Hepatocellular Carcinoma |
Q36388719 | A Bayesian nonrigid registration method to enhance intraoperative target definition in image-guided prostate procedures through uncertainty characterization |
Q37767397 | A review of low-dose-rate prostate brachytherapy--techniques and outcomes |
Q84960767 | Acute bowel morbidity after prostate brachytherapy with cesium-131 |
Q84565126 | Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131 |
Q44198117 | Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate? |
Q35556781 | Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers |
Q64950302 | Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. |
Q82498035 | Conservation of Erectile Function following Brachytherapy for Low-Risk Prostate Cancer |
Q33885592 | Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing |
Q36048698 | Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients |
Q47317738 | Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer |
Q50682319 | Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. |
Q34795596 | Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer |
Q47814066 | Experiences and psychological distress of spouses of prostate cancer patients at time of diagnosis and primary treatment. |
Q38217667 | Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study |
Q64327864 | Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients |
Q50088072 | Fully automatic deformable registration of pretreatment MRI/CT for image-guided prostate radiotherapy planning |
Q90247628 | Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study |
Q48570381 | Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study |
Q37300111 | Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy |
Q38863898 | Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? |
Q48407978 | Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy |
Q38943718 | Improvement of severe baseline lower urinary tract symptoms following robotic-assisted laparoscopic prostatectomy |
Q37402652 | Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management |
Q38754823 | Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade. |
Q40732738 | Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer |
Q24235544 | Low-dose rate brachytherapy for men with localized prostate cancer |
Q35079338 | Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review |
Q30386046 | Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants. |
Q37074954 | Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification |
Q51021374 | Outcomes after prostate brachytherapy are even better than predicted. |
Q53099080 | Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy. |
Q91713571 | Particle therapy for prostate cancer: The past, present and future |
Q43824418 | Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial |
Q47982004 | Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey |
Q36328572 | Physical and psychosocial side-effects of brachytherapy: a questionnaire survey. |
Q40054180 | Presentation, management, and outcomes of complications following prostate cancer therapy |
Q37766754 | Prostate cancer prevention: concepts and clinical recommendations |
Q87508347 | Prostate cancer: predicting high-risk prostate cancer-a novel stratification tool |
Q37686901 | Quality of Life and Sexual Health in the Aging of PCa Survivors |
Q34413524 | Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study |
Q83444422 | Quality of life among men with prostate cancer in rural Georgia |
Q33845930 | Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience. |
Q42182229 | Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression |
Q83863906 | Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study |
Q34315605 | Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials |
Q36355814 | Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer |
Q48064608 | Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil |
Q37118441 | State-of-the-art: prostate LDR brachytherapy |
Q51840365 | The natural history of voiding function after robot-assisted laparoscopic radical prostatectomy. |
Q38893692 | Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes. |
Q84201965 | Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience |
Q82740496 | [Quality of life after localized prostate cancer treatment] |
Q85273029 | [Sexuality and prostate cancer] |
Search more.